Joshua Schultz has been appointed chief executive officer, Cytel Inc. He succeeds Joseph Avellone, who acted as Cytel’s interim chief executive and will continue to serve on the company’s board. Mr. Schultz has a 20-year track record of success in life sciences and clinical research organizations. He joins Cytel from PAREXEL, where he most recently served as an officer of the company and senior vice president for its Access business unit.   Cyrus Mehta, co-founder of Cytel said, “As a rec...